Elutia (ELUT) Net Cash Flow Growth (1y) (2020 - 2026)
Elutia (ELUT) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 76.43% |
| 10 | Elutia | 38.98 Mn | 10.49 Mn | 1.80 Mn | -290.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -290.12% |
| Dec 31, 2025 | 353.02% |
| Sep 30, 2025 | -150.21% |
| Jun 30, 2025 | -256.98% |
| Mar 31, 2025 | 161.25% |
| Dec 31, 2024 | -362.70% |
| Sep 30, 2024 | 44.67% |
| Jun 30, 2024 | 326.11% |
| Mar 31, 2024 | -29.33% |
| Dec 31, 2023 | -46.46% |
| Sep 30, 2023 | 162.08% |
| Jun 30, 2023 | 82.14% |
| Mar 31, 2023 | 36.99% |
| Dec 31, 2022 | 13.92% |
| Sep 30, 2022 | -46.46% |
| Jun 30, 2022 | -554.24% |
| Mar 31, 2022 | 8.61% |
| Dec 31, 2021 | -79.41% |
| Sep 30, 2021 | -1,050.66% |
| Jun 30, 2021 | -615.22% |